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Interest in the concept of ‘food addiction’ (FA) is growing
steadily, and there is more and more evidence of similarities be-
tween substance dependence and excessive food intake. Research
with animal models supports the possibility of the developmentEur. Eat. Disorders Rev. 22 (2014) 389–396 © 2014 John Wiley & Sons, Ltd and Eating Disorderof addictive-like behaviours to some food components especially
to food high in sugar and fat (Nogueiras et al., 2012). In rats that
binged on sugar, neurochemical signs of dependence (e.g. changes
in dopamine and opioid receptor binding and repeated dopamine
and acetylcholine release in the nucleus accumbens) as well as
behavioural signs (e.g. increased intake after abstinence and cross389s Association.
Food Addiction and ED Subtypes R. Granero et al.sensitization with drugs of abuse) have been observed (Avena,
Bocarsly, & Hoebel, 2012; Avena, Rada, & Hoebel, 2008) although
in most instances, they do not become obese. Johnson and Kenny
demonstrated that the overconsumption of palatable high-fat
food triggered neuroadaptative responses in brain reward circuits
in obese rats that were similar to those seen in substance depen-
dence and that led to a pattern of compulsive eating (Johnson &
Kenny, 2010), although no signs of opiate-like withdrawal in
fat-bingeing rats were detected (Avena, 2010).
Findings from neuroimaging studies suggest that similar neu-
ronal circuits, modulated by dopamine, are activated in addiction
and obesity by either drugs or hyperpalatable food (Volkow,
Wang, Fowler, & Telang, 2008; Volkow, Wang, Fowler, Tomasi,
& Baler, 2012). Wang, Volkow, Thanos, and Fowler (2009) iden-
tiﬁed that in both conditions, there is a decreased availability of
dopamine D2 receptors and a decreased metabolism in the pre-
frontal regions involved in inhibitory control. Furthermore, other
authors (Gearhardt et al., 2011) observed that in a sample of lean
to obese young women, higher scores on the Yale FA Scale (YFAS)
were associated with similar patterns of neural activation to that of
substance dependence, such as elevated activation of the reward cir-
cuitry in response to food cues and reduced activation of inhibitory
regions in response to food intake. Although there are some behav-
ioural and neurobiological pieces of evidence supporting a food
addiction phenotype in humans, its validity is still controversial
(Hone-Blanchet & Fecteau, 2014; Ziauddeen & Fletcher, 2013).
Several studies have explored the possibility of ‘FA’ in humans.
Some of the ﬁrst authors to examine the prevalence of ‘FA’ in a
sample of women with binge eating disorder (BED) found that
92.4% met the Diagnostic and Statistical Manual of Mental Disor-
ders, fourth edition, (DSM-IV) criteria modiﬁed for substance
dependence, although the percentage was lower when using more
restrictive criteria (Cassin & von Ranson, 2007). Gearhardt and
colleagues (Gearhardt, Corbin, & Brownell, 2009a) examined
the diagnostic criteria for food dependence and other psycholog-
ical characteristics of addiction to develop the YFAS, the ﬁrst
validated tool to identify individuals with addictive behaviours
towards food in accordance with substance dependence criteria.
The YFAS was initially validated with a non-clinical sample
(Gearhardt, Corbin, & Brownell, 2009b), which showed adequate
reliability and validity, and was later assessed with samples of
obese adults (Gearhardt et al., 2012) and children (Gearhardt,
Roberto, Seamans, Corbin, & Brownell, 2013).
Some authors suggested that ‘FA’ could be a valid phenotype of
obesity, as in their sample of obese adults, 25% met diagnostic
criteria for ‘FA’ when assessed using the YFAS (Davis et al.,
2011). Similarly, in a sample of individuals seeking weight loss
treatment, 15% met the YFAS criteria for ‘FA’ (Eichen, Lent,
Goldbacher, & Foster, 2013), and in two different samples of bar-
iatric surgery individuals, 41.7% (Meule, Heckel, & Kübler, 2012)
and 53.7% (Clark & Saules, 2013) met the criteria for ‘FA’. Fi-
nally, in samples of obese adults with BED, 57% of predominantly
Caucasian individuals were classiﬁed as meeting ‘FA’ criteria
(Gearhardt et al., 2012), whereas in a racially diverse sample, the
percentage was of 41.5. Moreover, patients with a diagnosis of
BED who meet the YFAS criteria for ‘FA’ present more ED
pathology and associated psychopathology (Gearhardt et al., 2012;
Gearhardt, White, Masheb, & Grilo, 2013). This is speciﬁcally390 Eur. Eat. Disordersrelated to dopaminergic activation (Davis et al., 2013) and to
disinhibited eating and food craving (Burgess, Turan, Lokken,
Morse, & Boggiano, 2014).
After considering the existing literature on comorbidity between
EDs and other substance and non-substance-related disorders
(Calero-Elvira et al., 2009; Jiménez-Murcia et al., 2013; Speranza
et al., 2012), we hypothesized that a similar ‘FA’ pattern would be
observed in other subtypes of ED, particularly bulimia nervosa
(BN). To our knowledge, there are no studies that have explored
the prevalence of ‘FA’ in other EDs apart from BED and BN, namely
anorexia nervosa (AN), or ED not otherwise speciﬁed (EDNOS).
Neither is there research conducted with clinical populations that
are not of Anglo-Saxon origins, which questions the applicability
of the construct of ‘FA’ in other cultures.
Aims
The aims of our study were fourfold: (i) to translate the YFAS
(Gearhardt et al., 2009b) into Spanish and provide validation
scores of the YFAS-Spanish (YFAS-S) using a clinical sample of
adults with ED; (ii) to examine the prevalence of ‘FA’ and assess
differences in YFAS-S dependence criteria in ED patients com-
pared with healthy controls (HCs); (iii) to explore differences
between ED subtypes in ‘FA’ and among the YFAS-S dependence
criteria; and (iv) to examine the associations between YFAS-S
scoring, eating symptomatology and general psychopathology.
Method
Participants
Entry into the study was between September 2013 and March
2014. The ﬁnal sample included 207 participants [125 female
ED patients (40 AN, 54 BN, 18 EDNOS and 13 BED) and 82
healthy female controls (HCs)]. All ED patients were consecu-
tively admitted to the ED Units at the University Hospital of
Bellvitge and the Hospital de la Santa Creu i Sant Pau in
Barcelona, and all controls were from the same catchment area
as index patients. ED diagnoses were originally made according
to DSM-IV Text Revision (APA, 2000) criteria, using a semi-
structured clinical interview (Structured Clinical Interview for
DSM-IV Axis I disorders; First, Gibbon, Spitzer, & Williams,
1996) conducted by experienced psychologists and psychiatrists.
These diagnoses were reanalysed post hoc using the recent DSM-5
criteria (APA, 2013), as described recently (Machado, Goncalves,
& Hoek, 2013). The ED sample had a mean age of 29.3 years
(SD= 10.9), a mean age at onset of 19.0 years (SD= 7.6) and a
mean body mass index (BMI, kg/m2) of 23.2 (SD=7.5), and the
mean duration of the ED was 9.5 years (SD=9.5; median 5 years).
The HC sample comprised women who were visiting the hospital
for routine blood tests and students who volunteered. Mean age
was 23.4 years old (SD=5.3), and mean BMI was 21.3 kg/m2
(SD=3.0).
Patients were excluded from the analyses if they had missing
values for any diagnostic item. For the present analysis, from an
initial sample of 139 ED patients, the following individuals were
excluded: males (n= 3), as the number of men with ED diagnosis
was too small for a meaningful comparison, and 11 patients with
missing relevant data. Exclusion criteria for the HC group wereRev. 22 (2014) 389–396 © 2014 John Wiley & Sons, Ltd and Eating Disorders Association.
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sis of any substance or non-substance abuse disorder. The assess-
ment of a lifetime history of health or mental illness was based on
the general health questionnaire (General Health Questionnaire
28) (Goldberg & Hillier, 1979; Lobo, Pérez-Echeverría, & Artal,
2009). None of them were taking any medication.
The Ethics Committee of our institution (Ethics Committee
of Clinical Research of the Bellvitge University Hospital) ap-
proved this study, and written informed consent was obtained
from all participants.
Assessment
For the assessment, commonly applied questionnaires in the ﬁeld of
EDs, comprising the ED Inventory-2 (EDI-2) and the Symptom
Checklist-Revised (SCL-90-R) (Derogatis, 1990), were adminis-
tered. Additionally, the YFAS was used for measuring food addiction
construct (Gearhardt et al., 2009b). Furthermore, information
concerning clinical variables was assessed by means of a semi-
structured clinical interview (Fernandez-Aranda & Turon, 1998).
Yale Food Addiction Scale-Spanish (adapted from
Gearhardt et al., 2009b)
The YFASmeasures symptoms of food addiction, and its Spanish
translation version was used in the current study. This 25-item self-
report questionnaire was designed to measure food addiction
according to the seven symptoms of substance dependence listed
in the DSM-IV (e.g. withdrawal, tolerance, continued use despite
problems, vulnerability in social activities, etc.), modiﬁed for eating
behaviours. This instrument uses two scoring options to indicate
the experience of addictive eating behaviour; a dimensional score
(Likert scale) and a binary score. ‘FA’ is diagnosed when at least
three symptoms and a clinically signiﬁcant impairment or distress
(as assessed with two extra items) are present within the previous
12months. The validation of the English version shows an adequate
internal reliability and good convergent and incremental validity in
predicting binge eating (Gearhardt et al., 2009b).
The most common method of translation used for cross-
cultural research includes back-translation, consultation with
bilingual individuals who review the translation, and pre-testing
the translated measure for further revisions (Brislin, 1970). Both
linguistic and cultural differences inﬂuence the process of transla-
tion into another language. In the translation and back-translation
processes, linguistic and grammatical aspects are taken into account,
as well as possible cultural differences. Two translators that are spe-
cialists in the ﬁeld translated the YFAS from English into Spanish.
After, a third translator corrected the linguistic and grammatical
errors in the Spanish version. Finally, a fourth translator translated
the Spanish version back into English. A copy of the Spanish
translation can be obtained from the last author (Dr Fernando
Fernández-Aranda, ffernandez@bellvitgehospital.cat or fromAshley
Gearhardt, agearhar@umich.edu).
Eating Disorder Inventory-2 (Garner, 1991)
This is a reliable and valid 91-item multidimensional self-report
questionnaire that assesses different cognitive and behavioural char-
acteristics, which are typical for ED. The EDI-2 retains the 64 items
(grouped into eight scales: drive for thinness, bulimia, body
dissatisfaction, ineffectiveness, perfectionism, interpersonal distrust,Eur. Eat. Disorders Rev. 22 (2014) 389–396 © 2014 John Wiley & Sons, Ltd and Eating Disorderinteroceptive awareness, and maturity fears) of the EDI and adds 27
new items into three provisional scales: Asceticism, impulse regula-
tion, and social insecurity. All of these scales are answered on a
six-point Likert scale and provide standardized subscale scores.
This instrument was validated in a Spanish population (Garner,
1998) with a moderate mean internal consistency of α= 0.63.
Symptom Checklist-Revised ( Derogatis, 1990)
This test contains 90 items and helps measure nine primary
symptom dimensions of psychopathology, which are as follows:
(i) somatisation; (ii) obsession–compulsion; (iii) interpersonal
sensitivity (Se); (iv) depression; (v) anxiety; (vi) hostility; (vii)
phobic anxiety; (viii) paranoid ideation; and (ix) psychoticism.
In addition, it includes three global indices, which are a global
severity index (GSI), designed to measure overall psychological
distress, a positive symptom distress index (PSDI), designed to
measure the intensity of symptoms, and a positive symptom total
(PST), which measures self-reported symptoms. The GSI can be
used as a summary of the test. This scale has been validated in a
Spanish population (Derogatis, 2002), obtaining a mean internal
consistency of 0.75 (coefﬁcient alpha).
Statistical analysis
Conﬁrmatory factor analysis (CFA) with STATA13 for Windows
assessed the internal structure of the YFAS-S scale. The one-
dimensional solution was tested, using the maximum likelihood
and the robust estimator. Two CFA analyses were conducted:
one for the original items and one for the generated variables that
assess the eight DSM dependence criteria. Analyses were also
replicated for the whole sample (n= 207) and for the group of
ED patients (n= 125). Overall goodness-of-ﬁt statistics were
assessed through the root-mean-squared error of approximation
(a ﬁt was considered to be good for values lower than 0.10;
Kline, 2010) and coefﬁcient of determination (valuing the overall
predictive capacity of the model).
Receiver operating characteristic (ROC) analyses measured the
screening capacity of the YFAS-S scale scores to identify the
presence of an ED and the different subtypes.
Binary logistic regressions analysed the capacity of the YFAS-S
items to identify the presence of an ED, and a t-test procedure com-
pared YFAS-S dimensional score between HC and ED patients. The
comparison between ED subtypes was also carried out with binary
logistic models and analysis of variance (ANOVA) procedure.
Correlation coefﬁcients valued the association between YFAS-S
scale scores and clinical measures (for ED, general psychopathology
and personality traits). Because of the large sample size and the con-
sequent high statistical power, small correlations tended to achieve
statistical signiﬁcance, so the interpretation of r-coefﬁcients was
based on the own size: |r|< .20 poor relationship, .20< |r|< .30
moderate and |r|> .30 good.
Results
Psychometric properties of the YFAS-S
The YFAS-S binary screen score showed excellent speciﬁcity (Sp; 80
HCs met negative screen, Sp= 97.6%, 95% CI: 91.5 to 99.3%) and
moderate Se (91 ED patients met positive screen, Se= 72.8%, 95%391s Association.
Food Addiction and ED Subtypes R. Granero et al.CI: 64.4 79.8%). The area under the ROC curve measuring the va-
lidity of the YFAS-S dimensional score to screen between HC and
ED patients was excellent (area under ROC curve (AUC)= 0.901;
95% CI: 0.86 to 0.94). Considering DSM-5 ED subtypes, YFAS-S
binary screen score obtained Se= 60.0% and Sp= 58.7% for AN,
Se= 81.5% and Sp=68.0% for BN, Se= 76.9% and Sp=57.2%
for BED and Se= 72.2% and Sp= 57.7% for EDNOS. The YFAS-S
dimensional score achieved good AUC to discriminate the DSM-5
BN (AUC=0.83) and BED subtypes (AUC=0.84).
Other psychometric evidence for the YFAS-S is available as
supplementary material (Tables S1–S2). The capacity to discrim-
inate between HC and ED patients was statistically signiﬁcant
for all the original YFAS-S items, except for item 19 ‘consuming
even though emotional–physical problems’ and item 24 ‘successful
in reducing–stopping eating’, as well as for the YFAS-S dimensional
scores (Table S1).
Conﬁrmatory factor analysis achieved adequate goodness of ﬁt
for the one-dimensional solution both for the original YFAS-S
item codiﬁcation and for the generated YFAS-S binary DSM
dependence criteria (Table S2), and the only item with a non-
signiﬁcant coefﬁcient was item 24 ‘successful in reducing–
stopping eating’ for the model obtained into the ED sample.
Internal consistence measured through Cronbach’s alpha ranged
between moderate (α= .71, for the generated YFAS-S binary
dependence scores into the ED sample) and excellent (α= .95
for the original YFAS-S items into the whole sample).Prevalence of FA and comparison between HC and
ED subtypes
The prevalence of participants who met the criteria for the YFAS-S
‘FA’ was 72.8% in the ED sample and 2.4% in the HC sample
(χ2 = 99.1, d.f. = 1, p< .001). Based on DSM-5 taxonomy, differ-
ences in the YFAS-S binary screen between ED subtypes were not
statistically signiﬁcant (χ2 = 5.5, d.f. = 3, p= .140): 60.0% of ANTable 1 Prevalence of DSM dependence criteria (as measured by YFAS-S) and com
Prevalence (%)
HC ED
YFAS-S dependence criteria (prevalence comparison)
Consumed more than planned 4.88 53.60
Unable to cut down or stop 84.15 99.20
Great deal of time spent 10.98 63.20
Important activities given up 4.88 70.40
Use despite consequences 50.00 56.80
Tolerance 12.20 64.00
Withdrawal 7.32 59.20
Impairment or distress 4.88 80.00
Means
HC ED
YFAS-S score (number of dependence criteria met) 1.74 4.66
HC, healthy controls (n= 82); ED, eating disorder (n= 125); OR, odds ratio; MD, mean
*Moderate (|d|> .5) to **high (|d|> .8) effect size.
392 Eur. Eat. Disordersmet the YFAS-S binary positive screen, 81.5% of BN, 76.9% of
BED and 72.2% of EDNOS. Focusing on the AN subtypes, the
YFAS-S binary screen was positive for 50% of the AN restrictive
(AN-R) subtype compared with 85.7% of the AN binge–purging
(AN-BP) subtype, obtaining a quasi-signiﬁcant statistical result
and a high effect size for the difference (χ2 = 2.79, d.f. = 1, p= .095;
|d| = 0.83). The comparison of the prevalence of the YFAS-S binary
positive screen between the AN-R subtype and the cluster composed
by the other ED subtypes achieved a statistically signiﬁcant result
and a moderate effect size (50 vs 79.35%; χ2 = 7.89, d.f. = 1,
p= .005; |d| = 0.64).YFAS-S differences between ED subtypes
Table 1 shows the presence of DSM dependence criteria based on
the YFAS-S, among HC and ED patients. All the criteria achieved
statistical differences with high effect size (signiﬁcant lower prev-
alence for HC), except for the criterion ‘use continues despite
knowledge of adversity’. The mean for the YFAS-S dimensional
score was also statistically different and with a high effect size
comparing HC and ED patients (1.7 vs 4.7, t= 13.1, d.f. = 205,
p> .001, |d| = 1.96).
Table 2 shows the differences in the YFAS-S scores (for both
the YFAS-S binary variables measuring DSM addiction criteria
and the YFAS-S dimensional measure) between ED subtypes. As
a whole, the prevalence for the DSM addiction criteria was lowest
for the AN restricting subtype and the highest for BN, AN-BP and
BED. The DSM addiction criterion with many signiﬁcant pairwise
comparisons was ‘substance taken in larger amount for a longer
period than intended’ (the prevalence was equal for EDNOS
and AN, around 30–33.3%, and for BN and BED, it was around
72–77%). The DSM addiction criterion ‘clinical impairment–
distress’ only differed between AN-BN, and the prevalence of
the DSM addiction criterion ‘persistent desire–attempts to quit’
was near 100% in all the ED subtypes. The mean of the YFAS-Sparison between HC and ED patients
Logistic regression
p OR 95% CI (OR) |d|
<.001 22.53 7.77 65.3 1.27**
.003 23.36 2.99 182.4 0.57*
<.001 13.93 6.37 30.4 1.29**
<.001 46.38 15.82 136.0 1.84**
.337 1.31 0.75 2.30 0.14
<.001 12.80 6.01 27.2 1.26**
<.001 18.38 7.44 45.4 1.32**
<.001 78.00 26.06 233.4 2.34**
t-test mean comparison
p MD 95% CI (MD) |d|
<.001 2.92 2.48 3.36 1.96**
difference; |d|, Cohens’-d. Bold: signiﬁcant comparison (.05 level).
Rev. 22 (2014) 389–396 © 2014 John Wiley & Sons, Ltd and Eating Disorders Association.
Table 2 Differences on YFAS-S scores between ED diagnostic subtypes
Prevalence (%) Prevalence comparison (binary logistics)
EDNOS AN BN BED Group Pairwise comparison: OR (odds ratio)
Diagnosis for ED: DSM-5 1 (n= 18) 2 (n= 40) 3 (n= 54) 4 (n= 13) p 2 versus 1 3 versus 1 4 versus 1 3 versus 2 4 versus 2 4 versus 3
YFAS-S symptoms (%)
Consumed more than planned 33.3 30.0 72.2 76.9 <.001 0.86 5.20 6.67 6.07 7.78 1.28
Unable to cut down or stop 100.0 97.5 100.0 100.0 — — — — — — —
Great deal of time spent 66.7 32.5 79.6 84.6 <.001 0.24 1.96 2.75 8.12 11.42 1.41
Important activities given up 55.6 55.0 87.0 69.2 .006 0.98 5.37 1.80 5.49 1.84 0.34
Use despite consequences 44.4 55.0 55.6 84.6 .203 1.53 1.56 6.88 1.02 4.50 4.40
Tolerance 50.0 60.0 64.8 92.3 .172 1.50 1.84 12.0 1.23 8.00 6.51
Withdrawal 55.6 32.5 74.1 84.6 <.001 0.39 2.29 4.40 5.94 11.42 1.93
Impairment or distress 83.3 70.0 87.0 76.9 .241 0.47 1.34 0.67 2.88 1.43 0.50
Means Group Pairwise comparison: mean differences (ANOVA)
EDNOS AN BN BED p 2 versus 1 3 versus 1 4 versus 1 3 versus 2 4 versus 2 4 versus 3
YFAS-S diagnosis (mean) 4.06 3.63 5.33 5.92 <.001 0.43 1.28 1.87 1.71 2.30 0.59
ED, eating disorder; EDNOS, eating disorder not otherwise speciﬁed; AN, anorexia nervosa; BN, bulimia nervosa; BED, binge eating disorder.
Bold: signiﬁcant pair-wise comparison—not estimable.
R. Granero et al. Food Addiction and ED Subtypesdimensional score was lowest in AN, followed by EDNOS, BN
and BED (pairwise comparisons were not statistically signiﬁcant
for anorexia–EDNOS and bulimia–binge eating).Association between YFAS-S and external clinical
criteria
Table 3 shows correlations for the YFAS-S scores and external
clinical criteria, for both the ED patient sample and the total sam-
ple. As a whole, YFAS-S achieved good convergent validity com-
pared with the EDI-2 and the SCL-90-R scores. The BMI and
the number of binges per week also positively correlated with
the YFAS-S dimensional score (the highest values in BMI and in
the number of binges correspond to the highest YFAS-S scores).
Discussion
Besides providing a translation of the YFAS (Gearhardt et al.,
2009b) into Spanish (YFAS-S) and the validation scores, this
study examined the prevalence of ‘FA’ measured in a clinical
Spanish sample of female adults diagnosed with ED according to
DSM-5 criteria and assessed the differences in dependence criteria
between this group and HCs. A second main objective was to
explore associations between ‘FA’ scores, eating symptomatology
and general psychopathology.
Regarding our ﬁrst objective, we found that the YFAS-S had
excellent Sp and a moderate Se when comparing ED with HC.
The area under the ROC curve measuring the validity of the
YFAS-S dimensional score to screen HC and ED patients was
excellent. This result is in concordance with the psychometrical
properties of the original English version of the YFAS scale
(Gearhardt et al., 2009b) and suggests that this scale accurately
discriminates between clinical samples with abnormal eating
behaviour and healthy-eating controls.Eur. Eat. Disorders Rev. 22 (2014) 389–396 © 2014 John Wiley & Sons, Ltd and Eating DisorderSecondly, when comparing ED with HC, we found that 72.8%
of our patients diagnosed with ED met the cut-off point of the
YFAS-S for ‘FA’ (three or more dependence criteria and a
clinically signiﬁcant impairment or distress) and presented an av-
erage of 4.7 dependence symptoms. Up to now, the only ED sub-
types that have been studied in relation to ‘FA’ were BED and BN,
with the hypothesis that ‘FA’ would be especially frequent among
these patients. The prevalence rates found in BED range from 41.5
to 57% (Davis et al., 2011; Gearhardt et al., 2012, Gearhardt, White
et al., 2013), except in one study (Cassin & von Ranson, 2007)
whereby a prevalence of 92.4% was found. However, in this study,
a standardized measure of addictive behaviours towards food was
not used. In a study with women with current or remitted BN, 100%
of patients with current BN met ‘FA’ diagnosis, while only 30% of
women with remitted BN did (Meule, von Rezori, & Blechert, 2014).
The prevalence rate of the YFAS-S ‘FA’ in the Spanish HCs of
our study was just 2.4% (with a mean of 1.7 dependence criteria),
and this group did not present any general psychopathology. The
preliminary validation of the YFAS (Gearhardt et al., 2009b)
showed that 11.6% of their representative sample of an under-
graduate population met the ‘FA’ criteria, and in a German valida-
tion study predominantly conducted with students, 8.8% of the
participants fulﬁlled these criteria (Meule, Vögele, & Kübler,
2012). A lack of an accurate psychopathological screening in
previous studies may explain the discrepancy in the obtained
results, as well as the exclusion, in our study, of HCs with a
lifetime diagnosis of ED or a current diagnosis of any substance
or non-substance abuse disorder.
Thirdly, when considering the speciﬁc dependence criteria, the
overall prevalence was much higher in ED than in HCs, except for
the criterion ‘continued use despite negative consequences’,
which did not reach a signiﬁcant difference, and the criterion
‘unable to cut down or stop’, where the difference was signiﬁcant
but smaller. Moreover, patients diagnosed with ED experienced393s Association.
Table 3 Correlation between YFAS-S scores and ED and psychopathological
symptoms
ED patients (n= 125) Total sample (n= 207)
YFAS-S scores Dimensional† Binary‡ Dimensional† Binary‡
EDI-2: drive for thinness .421* .478* .649* .701*
EDI-2: body dissatisfaction .295 .288 .584* .587*
EDI-2: interoceptive awareness .407* .409* .630* .651*
EDI-2: bulimia .553* .420* .670* .612*
EDI-2: interpersonal distrust .246 .255 .537* .554*
EDI-2: ineffectiveness .142 .099 .344* .322*
EDI-2: maturity fears .265 .341* .397* .462*
EDI-2: perfectionism .203 .291 .436* .500*
EDI-2: impulse regulation .253 .323* .493* .559*
EDI-2: asceticism .180 .134 .454* .450*
EDI-2: social insecurity .141 .011 .029 .017
EDI-2: total score .397* .391* .638* .658*
SCL-90-R: somatisation .246 .198 .506* .492*
SCL-90-R: obsessive/compulsive .303* .186 .530* .479*
SCL-90-R: interpersonal sensitivity .343* .261 .565* .555*
SCL-90-R: depressive .364* .286 .618* .597*
SCL-90-R: anxiety .253 .257 .491* .502*
SCL-90-R: hostility .211 .133 .475* .432*
SCL-90-R: phobic anxiety .276 .217 .479* .465*
SCL-90-R: paranoid ideation .198 .204 .452* .477*
SCL-90-R: psychotic .292 .255 .555* .554*
SCL-90-R: GSI score .346* .285 .600* .588*
SCL-90-R: PST score .324* .229 .538* .515*
SCL-90-R: PSDI score .354* .328* .613* .607*
BMI (present) .398* .153 .368* .196
Age (years old) .142 .125 .275 .283
Binges per week .452* .253 — —
Vomits per week .216 .124 — —
Laxatives per week .091 .101 — —
Onset (years) .137 .128 — —
Evolution (years) .138 .111 — —
Number of treatments .195 -.122 — —
YFAS-S dimensional: total of DSM dependence criteria. YFAS-S binary: positive vs
negative classiﬁcation of ‘FA’.
†Pearson correlation.
‡Biserial point correlation.
*Good effect size (|r| ≥ .30).
— indicates that the measure was only available for ED patients.
Food Addiction and ED Subtypes R. Granero et al.signiﬁcantly more impairment or distress because of ‘FA’ symp-
toms than the HC. Comparison of ‘FA’ symptoms between ED di-
agnostic subtypes showed signiﬁcant differences in all dependence
criteria except for ‘unable to cut down or stop’. In contrast to
more restrictive or purge-only disorders (AN-R subtype and
EDNOS), patients diagnosed with EDs in which binges are
frequent (namely AN-BP subtype, BN and BED) tend to consume
more high-fat/high-sugar caloric food than planned, are more
likely to give up important activities and experience more with-
drawal symptoms. They therefore present a higher number of
dependence symptoms. This is consistent with the other obtained
results based on the ‘FA’ category, where AN-BP subtype showed
the highest scores (85.7%), followed by BN and BED (81.5 and394 Eur. Eat. Disorders76.9% respectively), whereas EDNOS and the AN-R subtype
displayed the lowest scores (72.2 and 50% respectively). Paradox-
ically, half of the patients who presented more restrictive features
(AN-R) also showed positive ‘FA’ scores. This result suggests that,
although patients with the AN-R subtype tend to show more
restrictive eating behaviours in order to suppress impulses of hun-
ger and a loss of control over food intake (Witt & Lowe, 2014),
they may nonetheless experience an internal subjective impulse
for disinhibition and a craving for food or hedonic eating.
Individuals with AN who exhibit more hedonic hunger for food
are also more prone to weight gain (Witt & Lowe, 2014) and
may potentially be more likely to exhibit signs of addictive-like
eating. These patients’ fears, and the accompanying cognitive dis-
tortions about food and weight, may also inﬂuence their subjec-
tive impression of their abnormal eating behaviour and what
they consider as excessive food intake (Gendall, Sullivan, Joyce,
& Bulik, 1997). The extent to which these patients are more likely
to present a diagnostic cross over along the course of their ED
(becoming AN-BP or BN over the years) could not be answered
in this study but should be assessed in the future. It has been pre-
viously proposed (Eddy et al., 2008) that 57.5% of patients with a
diagnosis of the AN restricting subtype cross over to the AN-BP
subtype or to BN during follow-up (55% to the AN-BP subtype
and 10% to BN), which makes the possible involvement of a sub-
jective ‘FA’ of clinical importance. Therefore, in future studies,
there are two aspects that may have to be taken into account. It
may be useful to analyse the potential relevance of subjective
disinhibition towards food in the AN-R subtype for the cross over
to other binge-related EDs over the course of the disorder.
Fourthly, regarding our ﬁnal objective, we found that the
YFAS-S dimensional/binary scores of the ED patients were posi-
tively associated with higher eating psychopathology and ED
severity. Thus, the presence of addiction-related symptoms seems
to be a sign of more severe eating pathology among ED patients.
In contrast to previous research (Davis et al., 2011; Eichen et al.,
2013), we found an association between BMI and YFAS-S symp-
tom scores, but this association was not signiﬁcant when the
classiﬁcation of ‘FA’ was considered, as recently described
(Burgess et al., 2014). As suggested in previous studies, BMI
may be a consequence of disinhibited eating behaviour rather
than a factor related to ‘FA’ (Villarejo et al., 2014). Moreover,
higher dimensional scores were also associated with the number
of binges per week but not with the number of vomits or use of
laxatives per week. This ﬁnding supports the hypotheses that the
YFAS should be associated with binge eating and not necessarily
to purging episodes and that the YFAS may not predict disordered
eating behaviour indiscriminately but is speciﬁcally linked to
disinhibited eating (Burgess et al., 2014). The development of
tolerance is a characteristic of addictive behaviours; in our sample,
64% of ED patients meet the YFAS-S tolerance criteria, in compar-
ison with only 12% of the HCs. In our study, differences in
tolerance among ED subtypes reached signiﬁcance when comparing
binging ED subtypes with restrictive ED subtypes. As other authors
have suggested (Burmeister, Hinman, Koball, Hoffmann, & Carels,
2013), higher tolerance and withdrawal symptoms are linked to
binge symptomatology and to poorer therapy response.
We did not ﬁnd an association between ‘FA’ scores and the age of
onset of the disorder, its duration, or with the number of treatments.Rev. 22 (2014) 389–396 © 2014 John Wiley & Sons, Ltd and Eating Disorders Association.
R. Granero et al. Food Addiction and ED SubtypesFurthermore, higher scores on the YFAS-S and a ‘FA’ classiﬁca-
tion were associated with a higher general psychopathology
(namely depressive and obsessive–compulsive symptomatology,
as well as interpersonal Se). These results are in accordance with
studies conducted with patients with BED, which found that more
addiction-related symptoms were associated with higher levels of
negative affect and more severe eating pathology (Gearhardt
et al., 2012, Gearhardt, White et al., 2013; Meule et al., 2014).
Furthermore, research has recently shown that emotional eating,
especially in response to negative emotions, signiﬁcantly moderates
the relationship between mood and food intake (Cebolla, Barrada,
van Strien, Oliver, & Baños, 2014; Van Strien et al., 2013; Zhu
et al., 2012; Espeset et al., 2012).
Limitations
Although the current study addresses a number of gaps in the lit-
erature, there are limitations to consider. First, the current study
was conducted solely with female participants because of the small
number of male ED patients. Thus, it is unclear whether these ﬁnd-
ings could be generalized to men. Secondly, compared with the AN
and BN groups, the BED group was rather small (n=13), which
could have hidden some interesting ﬁndings, and the HC sample
was slightly younger than the clinical groups. Finally, the study is
cross sectional; therefore, it is unclear whether addictive-like eating
behaviour is a cause, correlate or consequence of disordered eating.
An important step for the future is to conduct longitudinal
analyses on the association between addictive-like eating and dis-
ordered eating. Of special importance is the assessment of
whether higher scores on the YFAS are predictive of differential
responses to ED treatments. Furthermore, as recently suggested
with regard to the concept of hedonic eating (Witt & Lowe,Eur. Eat. Disorders Rev. 22 (2014) 389–396 © 2014 John Wiley & Sons, Ltd and Eating Disorder2014), the food addiction construct should be further analysed
to understand the loss of control over eating in AN and its poten-
tial link to the reported diagnostic cross over from the AN-R
subtype to the AN-BP subtype, as it has been previously described
(Eddy et al., 2008). Research in addictive-like eating patterns also
needs to be extended to samples of emotional eaters and to sam-
ples of people with substance or non-substance abuse disorder, as
well as to general population samples.
Conclusions
The results of this study support the good psychometrical proper-
ties (internal structure and discriminative capacity to differentiate
between ED and controls) of the Spanish version of the YFAS.
Higher YFAS-S scores are associated with the bingeing ED
subtype (namely AN-BP, BN and BED), with more severe eating
pathology and overall psychopathology (namely negative affect
and depression) and a greater BMI. Although the ‘FA’ construct
is able to differentiate between ED and HC, it needs to be further
explored and tested to understand its implication in the diagnostic
cross over in AN and its predictive capacity regarding response
to treatment.
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